SECsense Logo

Centessa Pharmaceuticals PLC 8-K Report: Key Financial Insights & Stock Information

$CNTA
Form 8-K
Filed on: 2025-02-21
Source
Centessa Pharmaceuticals PLC 8-K Report: Key Financial Insights & Stock Information

Here are the key insights extracted from the provided financial report section:

  1. Company Identification:
  • Name: Centessa Pharmaceuticals PLC
  • CIK: 0001847903
  • IRS Employer Identification Number: 98-1612294
  • Address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, WA14 2DT, GB
  • Contact Number: +1 617 468-5770
  1. Filing Information:
  • Filing Type: 8-K
  • Filing Date: February 14, 2025
  • SEC Filing Identifier: 001-40445
  1. Stock Information:
  • Ordinary Shares: Nominal value of £0.002 per share.
  • American Depositary Shares (ADS): Each representing one ordinary share, also with a nominal value of £0.002.
  1. Stock Exchange Listing:
  • Exchange: NASDAQ
  • Stock Ticker: CNTA
  1. Contextual Information:
  • The report includes information relevant to the common stock and American Depositary Shares of Centessa Pharmaceuticals, indicating the structure of the company’s equity.
  1. Document Structure:
  • The report is formatted in XBRL (eXtensible Business Reporting Language), which is used for electronic reporting of financial data to the SEC.

This summary encapsulates the essential details of the filing and the company’s stock structure, which is crucial for investors and analysts assessing Centessa Pharmaceuticals PLC.